One such region is East Asia, where polymorphic mutations to aldehyde dehydrogenase 2 (ALDH2) or alcohol dehydrogenase 1B (ADH1B) are associated with an increased risk of developing ESCC [6]. The gene discussed is ADH1B; the disease is esophageal squamous cell carcinoma.